The Alibaba, SoftBank and Xiaomi-backed mobile charger producer has floated below its range in a $150m initial public offering.

Intel Capital exited the spatial sound technology developer through an acquisition by Google in December last year.

The Novo-backed musculoskeletal disease therapy developer's market capitalisation stood at $1.6bn as of close of trading yesterday.

GV and Alexa Fund have exited the sports discussion app's owner, Betty Labs, in an acquisition of undisclosed size by Spotify.

The Amazon-backed food delivery service raised $2.07bn in its initial public offering only to see its shares fall some 25% on its opening day.

The online learning platform developer spun out of Stanford University priced its shares at the top of their range.

CWRU and UTMC-linked Rodeo Therapeutics is set to be acquired by Amgen for $55m in upfront and up to $666m in milestone payments.

Achilles Therapeutics has raised more than $175m in its initial public offering on the Nasdaq Global Select Market.

The Seek Group, Laureate Education and BCC-backed online learning platform developer priced its shares at the top of their range.

SoftBank’s SB Management subsidiary, Illumina and Novartis are backing a $375m PIPE supporting the deal, which values the proteomics technology provider at $1.23bn.